Clinical trials
Phase 1/2 Uterine Cervical Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
135 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 5 |
| 2003 | 4 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 5 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 3 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 10 |
| 2021 | 9 |
| 2022 | 10 |
| 2023 | 16 |
| 2024 | 10 |
| 2025 | 12 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 49 |
| Recruiting | 33 |
| Terminated | 22 |
| Active, not recruiting | 12 |
| Unknown status | 8 |
| Withdrawn | 5 |
| Not yet recruiting | 5 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 10 |
| University Health Network, Toronto | 4 |
| Cancer Research UK | 3 |
| Genmab | 3 |
| Incyte Biosciences International Sàrl | 3 |
| Peking Union Medical College Hospital | 3 |
| Agenus Inc. | 2 |
| Evopoint Biosciences Inc. | 2 |
| Fuda Cancer Hospital, Guangzhou | 2 |
| Klus Pharma Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 135 |
| Ovarian Neoplasms | 44 |
| Carcinoma, Non-Small-Cell Lung | 37 |
| Endometrial Neoplasms | 37 |
| Squamous Cell Carcinoma of Head and Neck | 29 |
| Esophageal Neoplasms | 26 |
| Stomach Neoplasms | 26 |
| Melanoma | 24 |
| Breast Neoplasms | 23 |
| Head and Neck Neoplasms | 20 |
Trials
Showing 1 to 25 of 135. Each trial links to its page on Pharma Observatory.
35 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.